Dr Martens swings to half-year loss as sales slump

Dr Martens (DOCS) shareholders have had a tough ride since the bootmaker’s London listing in January 2021. Its share price has tumbled 84 per cent since the pandemic-era IPO and is down more than 40 per cent over the past year.